期刊文献+

利巴韦林与eIF4E相关性急性髓系白血病的研究进展 被引量:1

原文传递
导出
摘要 人真核细胞翻译起始因子4E(eIF4E)特异性地与真核细胞mRNA7-甲基鸟嘌呤核苷(m7G)帽状结构结合,在帽状结构依赖的翻译起始阶段起限制性调控作用。其高表达于急性髓系白血病(AML)部分类型等多种恶性肿瘤。利巴韦林(ribavirin)与m7G帽状结构相似,并可阻碍其活性。体外及临床研究均发现,利巴韦林对eIF4E相关性AMI,有抑制作用,少部分患者达完全缓解,其疗效与患者是否表达FMS样酪氨酸激酶3(FLT3)及核磷蛋白(NPM)基因突变无关。
机构地区 泸州医学院
出处 《国际输血及血液学杂志》 CAS 2013年第3期244-246,共3页 International Journal of Blood Transfusion and Hematology
基金 四川省卫生厅科研课题(416001004081028)
  • 相关文献

参考文献26

  • 1Kentsis A, Topisirovic I, Culjkovic B, et al. Rihavirin suppresses elF4E- mediated oncogenie transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proe Natl Acad Sci USA, 2004, 101(52): 18105-18110.
  • 2Kentsis A, Volpon L, Topisirovic I, et al. Further evidence that ribavirin interacts with eIF4E. RNA, 2005, 11 (12): 1762- 1766.
  • 3Culjkovie B, Tan K, Orolicki S, et al. The eIF4E RNA regulon promotes the Akt signaling pathway. J Cell Biol, 2008, 181(1) : 51-63.
  • 4Topisirovic I, Borden KL. Homeodomain proteins and eukaryotic translation initiation factor 4E ( eIF4E ):an unexpected relationship. Histol Histopathol, 2005, 20 (4): 1275-1278.
  • 5Ruggero D, Montanaro L, Ma L, et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-myc in lymphomagenesis. Nat Med, 2004, 10(5): 484-486.
  • 6Culjkovie B, Topisirovic I, Borden KL. Controlling gene expression through RNA regulons: the role of the eukaryotie translation initiation factor eIF4E. Cell Cycle, 2007, 6(1) : 65-69.
  • 7Brown CJ, Verma CS, Walkinshaw MD, et al. Crystallization of eIF4E complexed with elF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site. Cell Cycle, 2009, 8(12): 1905-1911.
  • 8Borden KL. Targeting the oneogene eIF4E in cancer: from the bench to clinical trials. Clin Invest Med, 2011, 34(6): E315.
  • 9Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59(4): 225-249.
  • 10Dong K, Wang R, Wang X, et al. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Res Treat, 2009, 113(3): 443-456.

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部